MCRB - Seres Therapeutics Inc
9.32
0.190 2.039%
Share volume: 60,322
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$9.13
0.19
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-13-2024 | 11-13-2024 | 03-13-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | |
| Cash flow financing | 18.762 M | 0.000 | -110.871 M | 1.737 M | 1.180 M | 0.000 | 61.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 13.516 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -16.536 M | 0.000 | -4.408 M | -37.235 M | 28.056 M | 0.000 | 2.259 M | |
| Net income | -40.133 M | -32.870 M | 88.776 M | -15.637 M | 32.682 M | -19.855 M | 8.204 M | |
| Depreciation | 1.559 M | 1.420 M | 1.404 M | 1.085 M | 1.076 M | 1.059 M | 1.044 M | |
| Changes in inventories | 12.326 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -62.000 K | 1.302 M | 141.143 M | -90.000 K | -34.000 K | -181.000 K | -8.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 62.000 K | 99.000 K | 129.000 K | 90.000 K | 34.000 K | 181.000 K | 8.000 K | |
| Cash Change | -16.536 M | -38.509 M | -4.408 M | -37.235 M | 28.056 M | -13.470 M | 2.259 M |